Upregulation of TCF1 and BCL11B in CD8+ effector T cells predicts favorable response to ibrutinib in patients with chronic lymphocytic leukemia.
Saved in:
| Title: | Upregulation of TCF1 and BCL11B in CD8+ effector T cells predicts favorable response to ibrutinib in patients with chronic lymphocytic leukemia. |
|---|---|
| Authors: | Liu, Ge1 (AUTHOR), Liang, Taotao1 (AUTHOR), Ai, Hao1 (AUTHOR), Wang, Shan1 (AUTHOR), Yin, Songke1 (AUTHOR), Wang, Xiaojiao1,2 (AUTHOR), Wu, Hongfei1 (AUTHOR), Wang, Qian1 (AUTHOR), Zhao, Hongmian3 (AUTHOR), Liu, Xiaojuan4 (AUTHOR), Luv, Xiaodong1 (AUTHOR), Liu, Jia1 (AUTHOR), Yin, Qingsong1 (AUTHOR) jnyinqingsong@163.com |
| Source: | Communications Biology. 5/8/2026, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
